Lysine

Lysine

SCHEMBL1042282

NC(N)=O.NCCCC[C@H](N)C(=O)O

nearest known ligand 0.91

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

PPARDPTGS1PTGS2dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Lysine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSR P00390 1/20 0.91
ARG2 P78540 4/20 0.55
ARG1 P05089 3/20 0.55
RNPEP Q9H4A4 1/20 0.54
NOS2 P35228 6/20 0.53
CYP1A2 P05177 2/20 0.53
TSHR P16473 2/20 0.53
CYP2C19 P33261 2/20 0.53
GLA P06280 1/20 0.53
NFKB1 P19838 1/20 0.53
APEX1 P27695 1/20 0.53
NOS1 P29475 4/20 0.53
NOS3 P29474 3/20 0.53
CYP3A4 P08684 1/20 0.53
BLM P54132 2/20 0.52
KMT2A Q03164 2/20 0.52
ALOX15 P16050 1/20 0.52
PMP22 Q01453 1/20 0.52
MEN1 O00255 1/20 0.50
DDAH1 O94760 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Lysine SCHEMBL15286920 1.00 GSR (0.91) GSRARG2ARG1RNPEPNOS2
Lysine SCHEMBL28200568 0.98 GSR (0.87) GSRARG2ARG1RNPEPNOS2
Lysine SCHEMBL28200566 0.98 GSR (0.87) GSRARG2ARG1RNPEPNOS2
Lysine SCHEMBL5060018 0.95 GSR (0.91) GSRARG2ARG1RNPEPNOS2
Lysine SCHEMBL31644218 0.95 GSR (0.91) GSRARG2ARG1RNPEPNOS2
Lysine SCHEMBL4641859 0.95 GSR (0.91) GSRARG2ARG1RNPEPNOS2
Lysine SCHEMBL31039861 0.95 GSR (0.91) GSRARG2ARG1RNPEPNOS2
Lysine SCHEMBL1645 0.95 GSR (1.00) GSRARG2ARG1RNPEPNOS2
Lysine SCHEMBL12867528 0.95 GSR (1.00) GSRARG2ARG1RNPEPNOS2
Lysine SCHEMBL7343 0.95 GSR (1.00) GSRARG2ARG1RNPEPNOS2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2013142969-A1 URETHANES AND UREAS AND PROCESSES GAO JIAN PING (CA) 2013-10-03 WO claimed
CN-116348148-A Engineered extracellular vesicles exhibiting enhanced pharmacokinetics 医福斯治疗有限公司 2023-06-27 CN disclosed
CN-109311827-A Prostate specific membrane antigen targeted high affinity agents for intracavitary radiotherapy of prostate cancer 约翰霍普金斯大学 2019-02-05 CN disclosed
US-9644221-B2 Method of producing chemical by continuous fermentation and continuous fermentation apparatus TORAY INDUSTRIES, INC. (JP) 2017-05-09 US disclosed
EP-2837687-B1 METHOD FOR PRODUCING CHEMICAL BY MEANS OF CONTINUOUS FERMENTATION AND CONTINUOUS FERMENTATION DEVICE TORAY INDUSTRIES (JP) 2017-02-22 EP disclosed
US-20150056665-A1 METHOD OF PRODUCING CHEMICAL BY CONTINUOUS FERMENTATION AND CONTINUOUS FERMENTATION APPARATUS TORAY INDUSTRIES, INC. (JP) 2015-02-26 US disclosed
EP-2837687-A1 METHOD FOR PRODUCING CHEMICAL BY MEANS OF CONTINUOUS FERMENTATION AND CONTINUOUS FERMENTATION DEVICE Toray Industries, Inc. (JP) 2015-02-18 EP disclosed
CN-104284918-A Urethanes and ureas and processes GAO JIANPING 2015-01-14 CN disclosed
WO-2013142969-A1 URETHANES AND UREAS AND PROCESSES GAO JIAN PING (CA) 2013-10-03 WO disclosed
EP-1480941-B1 UREA DERIVATIVES AS HIV ASPARTYL PROTEASE INHIBITORS AMBRILIA BIOPHARMA INC (CA) 2011-01-26 EP disclosed
EP-1480941-A2 UREA DERIVATIVES AS HIV ASPARTYL PROTEASE INHIBITORS Procyon Biopharma Inc. (CA) 2004-12-01 EP disclosed
WO-2003074467-A2 UREA DERIVATIVES AS HIV ASPARTYL PROTEASE INHIBITORS PROCYON BIOPHARMA INC. (CA) 2003-09-12 WO disclosed
US-6528532-B1 Benzenesulfonamide group PHARMACOR INC. (CA) 2003-03-04 US disclosed